Strowitzki, T. (2016). Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART). BioMed Central.
Chicago Style (17th ed.) CitationStrowitzki, Thomas. Randomized, Active-controlled, Comparative Phase 3 Efficacy and Safety Equivalence Trial of Ovaleap® (recombinant Human Follicle-stimulating Hormone) in Infertile Women Using Assisted Reproduction Technology (ART). London: BioMed Central, 2016.
MLA (9th ed.) CitationStrowitzki, Thomas. Randomized, Active-controlled, Comparative Phase 3 Efficacy and Safety Equivalence Trial of Ovaleap® (recombinant Human Follicle-stimulating Hormone) in Infertile Women Using Assisted Reproduction Technology (ART). BioMed Central, 2016.